Literature DB >> 24119847

Role of vitamin D receptor activation in racial disparities in kidney disease outcomes.

Utibe Essien1, Narender Goel, Michal L Melamed.   

Abstract

African Americans have lower 25-hydroxyvitamin D (25(OH)D) levels compared with whites. African Americans also have a higher risk of developing albuminuria and end-stage renal disease but a lower risk of death once they commence hemodialysis compared with whites. Vitamin D levels have been associated with multiple outcomes including albuminuria, progression to end-stage renal disease, and all-cause and cardiovascular mortality. In this review, we examine the evidence linking 25(OH)D to outcomes and the possibility that differential 25(OH)D may explain certain racial differences in outcomes.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Vitamin D; albuminuria; chronic kidney disease; mortality; racial differences

Mesh:

Substances:

Year:  2013        PMID: 24119847      PMCID: PMC4378565          DOI: 10.1016/j.semnephrol.2013.07.003

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  96 in total

1.  Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.

Authors:  Catherine C Cowie; Keith F Rust; Danita D Byrd-Holt; Mark S Eberhardt; Katherine M Flegal; Michael M Engelgau; Sharon H Saydah; Desmond E Williams; Linda S Geiss; Edward W Gregg
Journal:  Diabetes Care       Date:  2006-06       Impact factor: 19.112

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

Authors:  Diana M Antoniucci; Takeyoshi Yamashita; Anthony A Portale
Journal:  J Clin Endocrinol Metab       Date:  2006-05-30       Impact factor: 5.958

4.  The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese Black Americans.

Authors:  Lisa B Yanoff; Shamik J Parikh; Amanda Spitalnik; Blakeley Denkinger; Nancy G Sebring; Pamela Slaughter; Theresa McHugh; Alan T Remaley; Jack A Yanovski
Journal:  Clin Endocrinol (Oxf)       Date:  2006-05       Impact factor: 3.478

5.  Plasma 25-hydroxyvitamin D levels and risk of incident hypertension.

Authors:  John P Forman; Edward Giovannucci; Michelle D Holmes; Heike A Bischoff-Ferrari; Shelley S Tworoger; Walter C Willett; Gary C Curhan
Journal:  Hypertension       Date:  2007-03-19       Impact factor: 10.190

6.  Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy.

Authors:  Y Wang; J Zhou; A W Minto; B K Hack; J J Alexander; M Haas; Y C Li; C W Heilig; R J Quigg
Journal:  Kidney Int       Date:  2006-07-05       Impact factor: 10.612

7.  Treatment with 1,25-dihydroxyvitamin D3 preserves glomerular slit diaphragm-associated protein expression in experimental glomerulonephritis.

Authors:  M Migliori; L Giovannini; V Panichi; C Filippi; D Taccola; N Origlia; C Mannari; G Camussi
Journal:  Int J Immunopathol Pharmacol       Date:  2005 Oct-Dec       Impact factor: 3.219

8.  The impact of routine vitamin supplementation on serum levels of 25 (OH) D3 among the general adult population and patients with chronic kidney disease.

Authors:  Naureen Tareen; David Martins; Ashraf Zadshir; Deyu Pan; Keith C Norris
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

9.  The prevalence of hypovitaminosis D among US adults: data from the NHANES III.

Authors:  Ashraf Zadshir; Naureen Tareen; Deyu Pan; Keith Norris; David Martins
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

10.  25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III).

Authors:  Ian H de Boer; George N Ioannou; Bryan Kestenbaum; John D Brunzell; Noel S Weiss
Journal:  Am J Kidney Dis       Date:  2007-07       Impact factor: 8.860

View more
  4 in total

1.  Effects of vitamin D on renal fibrosis in diabetic nephropathy model rats.

Authors:  Yanyan Tian; Guodong Lv; Ye Yang; Yuanyuan Zhang; Rui Yu; Jia Zhu; Lati Xiao; Jun Zhu
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

2.  Antifibrotic vitamin D analogs.

Authors:  Joseph V Bonventre
Journal:  J Clin Invest       Date:  2013-10-25       Impact factor: 14.808

3.  Prevention of apoptosis averts glomerular tubular disconnection and podocyte loss in proteinuric kidney disease.

Authors:  Ievgeniia Burlaka; Linnéa M Nilsson; Lena Scott; Ulla Holtbäck; Ann-Christine Eklöf; Agnes B Fogo; Hjalmar Brismar; Anita Aperia
Journal:  Kidney Int       Date:  2016-05-21       Impact factor: 10.612

4.  Both serum 25-hydroxyvitamin D and calcium levels may increase the risk of incident prostate cancer in Caribbean men of African ancestry.

Authors:  Maria D Jackson; Marshall K Tulloch-Reid; Carole M Lindsay; Garrett Smith; Franklyn I Bennett; Norma McFarlane-Anderson; William Aiken; Kathleen C M Coard
Journal:  Cancer Med       Date:  2015-04-07       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.